The World Adoptive T-Cell Therapy Summit 2017 is dedicated to the current issues on Adoptive T-Cell Therapy.
Topics
- Efficacy in different cancer models
- Advancements in T-cell engineering
- Commercialisation of Viable T-cell therapies
- Results from human and clinical studies
- Developing adoptive cell therapies for solid tumors
- Scaling and manufacture of T-cells
- Critical components needed to make adoptive T cell therapies viable
- Clinical case studies on T cell receptors and their biology
- Efficacy in different cancer models
- Advancements in T-cell engineering
Who should Attend
Senior attendees from pharmaceutical, biotechnology and research Institutes involved in:
- Clinical Operations
- Clinical Research/Development
- Cancer Immunotherapy
- Clinical Oncology
- Translational Research/Development/Medicine
- Immunology
- R&D Innovation & Strategy
- Medical Affairs
- Business Development
- Biomarkers
- Licensing
- Corporate Venture
- Negotiations
- Strategic Partnerships
- Commercial Innovation
